Risks and complications to the facial bones after bisphosphonates use

Abstract

The bisphosphonates (BFs) as a drug-related inhibition of bone resorption consecrates its to the treatment of patients with osteoporosis and cancer with bone metastases, which culminated with its expanded use. This study aims to explain the importance of identifying patients who make use of BFs thereby contributing to the adequate knowledge on risks related to these complications affecting patients. This study focuses on the clinical use of BFs, the risks it represents to the facial bones, considered its characteristics as well as the importance of diagnosing patients who use these drugs, in order to conduct them on the proper dental treatment to be held initially, and thus, to contribute to the reduction of complication that means an unforeseeable and devastating consequences for the patients.